Literature DB >> 8697987

[The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].

L Qin1, Z Tang, K Liu.   

Abstract

We have combined the polymerase chain reaction (PCR) with the HaeIII enzyme restriction analysis to study the mutations at codon 249 of p53 gene in L02 human liver cell line, Bel-7402, SMMC-7721 human hepatocellular carcinoma cell lines and 19 surgical specimens of hepatocellular carcinoma (HCC) and their surrounding non-cancer liver tissues. None of the three cell lines and the non-cancer liver tissues was found to have p53 mutation; but 10 of 19 HCC samples (52.6%) had p53 point mutations, and the p53 gene mutated more frequently in HCC with incomplete capsule, intrahepatic metastasis, or multiple nodules than in those with well encapsulated (70% vs 33.3%, P < 0.05), no intrahepatic metastasis (71.4% vs 41.6%, P < 0.05) and single nodule (83.3% vs 38.5%, P < 0.05). These suggested that the codon 249 was a mutational hotspot of the p53 gene in human HCC seen in China, and p53 mutations may be related to invasiveness of human HCC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8697987

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  Qi Niu; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lian-Hai Zhang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Codon 249 mutations of p53 gene in development of hepatocellular carcinoma.

Authors:  Xiao-Mou Peng; Wen-Wei Peng; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.